British Business Bank Anchors Longwall’s New Deeptech Fund
Longwall Venture has raised a £50 million anchor commitment for its latest fund. The capital comes from the British Business Bank through its Enterprise Capital Funds programme. The support strengthens the firm’s long-standing relationship with the institution. The programme has backed Longwall since its first fund in 2008. The new vehicle, Longwall 4, now holds £86.2 million of commitments. The firm is close to its £100 million target.
Longwall said the UK continues to generate strong early-stage science through academic and industrial research. It believes these discoveries face funding gaps during commercial development. The firm said this limits the ability of founders to scale. Managing partner David Denny said the country has a rich pipeline of innovation. He added that strong research requires patient capital. He said the fund will target companies that turn science into usable products.
The new fund will invest between £500,000 and £2 million in early-stage deeptech companies. The firm plans to back up to 16 startups. It will also reserve follow-on capital. The strategy focuses on clean energy, life sciences, advanced manufacturing and defence. Longwall said these sectors require long development cycles. It believes targeted capital can unlock commercial potential.
Longwall has a strong track record in UK deeptech. Its first fund backed OrganOx. The medtech company later sold for more than $1.5 billion. The exit delivered a 19.2x return for investors. The firm said the outcome shows the value of long-term support. Its portfolio today spans medical devices, aerospace and defence.
Growing Deeptech Momentum Across the UK
Industry voices view the British Business Bank’s investment as a positive signal. Mark Sims, managing director at the institution, praised previous outcomes. He said the programme helps early-stage investors raise capital. He added that cornerstone investments help startups secure scale-up funding. He said the new support will uncover the next generation of UK breakthroughs.
Business Secretary Peter Kyle welcomed the commitment. He said the funding provides a boost to the technology sector. He praised the ability of UK research to compete globally. He said the fund helps founders build at home. He noted that scientific development often moves abroad without strong capital support. He believes this investment reinforces the country’s industrial strategy.
Longwall said interest in UK deeptech has accelerated. Research institutions continue to generate patents and prototypes. The firm said this growth encourages specialised investors. It also attracts corporate partners. The new fund will help founders move from lab to market. Longwall said many researchers need guidance on product development. It believes its team can bridge that gap.
The firm remains an active supporter of founder diversity. It does not operate a formal diversity mandate. It is a signatory of the Investing in Women Code. The initiative promotes better access to resources for female entrepreneurs. Longwall said support for diverse founders strengthens the innovation landscape.
Commercialising Scientific Research for Scalable Impact
A visual representation of how strong scientific research evolves into market-ready deeptech innovations through collaboration, patient capital and commercial discipline. Source: Created by Ventureburn.
Longwall said science commercialisation requires more than laboratory progress. Early founders must secure industry partners. They must also meet regulatory standards. Many deeptech founders require patient capital. The firm said this is where specialist investors create value. It aims to support teams from early prototype to market entry.
The firm’s approach evaluates scientific feasibility. It also checks market fit at an early stage. Longwall said this method reduces risk. It also helps teams work with industrial partners. Early funds showed that detailed oversight accelerates progress. OrganOx demonstrated that scientific breakthroughs can reach global markets. The company built major clinical impact through steady investment.
The new fund will target companies working on clean energy systems. It will also invest in emerging life sciences and defence technologies. Longwall said the UK has global strength in these fields. It highlighted advancements in advanced materials, robotics and biotech. The firm said strong science can deliver jobs and export opportunities. It expects the new fund to support these outcomes.
Deeptech companies often require longer timelines than software startups. Longwall said these companies create defensible value. Research builds intellectual property. This protects against competition. Investors view this as a long-term advantage. The firm said strong science combined with commercial discipline produces global winners.
Impact of Anchor Funding on the UK Deeptech Pipeline
Anchor funding signals confidence in the sector. The British Business Bank has backed each Longwall fund. This continuity helps the firm raise capital. It also encourages private investors to join new vehicles. Longwall said this stability supports founders. Startups rely on investors who commit across funding rounds.
Government support also matters. Business Secretary Peter Kyle said UK research drives national competitiveness. He said investment helps the country maintain leadership. The British Business Bank’s involvement ensures that founders across regions receive support. It also helps clusters in Oxford, Cambridge and London grow.
Longwall said its new fund will prioritise companies solving real problems. It believes science must meet commercial needs. The firm expects strong demand for solutions that support sustainable energy. It also sees growth potential in next-generation healthcare. Defence technology also remains a priority. The firm said these sectors require robust funding to scale.
Longwall expects deeptech momentum to continue. It said UK founders now work on global challenges. Investors worldwide monitor UK breakthroughs. Strong exits attract more capital. The firm believes early-stage support remains essential. It plans to maintain long-term relationships with founders.
To stay updated on crypto venture capital funding and market trends, visit our venture capital news section for more insights.
